Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide 3 mg in Obese Women with PCOS
NCT03480022Phase 3Completed
- Sponsor
- Woman's
- Start
- Sep 2018
- Primary completion
- Feb 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in obesity, polycystic ovary syndrome (PCOS), sponsored by Woman's. Started Sep 2018; status: completed.
02
Drugs
03
Conditions
obesitypolycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03480022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03480022.